AIM
ONCS

Acrospire Investment Management’s OncoSec Medical Incorporated ONCS Stock Holding History

Acrospire Investment Management’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-13
Closed -$3K – 1883
2017
Q2 		$3K Sell
13
-70
-84% -$17.2K ﹤0.01% 2051
2017
Q1 		$23K Buy
83
+45
+118% +$13.1K 0.02% 1557
2016
Q4 		$10K Buy
+38
New +$13K ﹤0.01% 1955
2016
Q3 		– Sell
-5
Closed -$2K – 2280
2016
Q2 		$2K Buy
+5
New +$2.11K ﹤0.01% 1959

Other funds holding ONCS

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Zurich Cantonal Bank
Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acrospire Investment Management's ONCS Position: Q3 2017 in Review

Acrospire Investment Management sold out of OncoSec Medical Incorporated (ONCS) in Q3 2017, closing a stake of 13 shares — an estimated $3K sold.

Acrospire Investment Management first reported a position in ONCS in Q2 2016 and held it in 4 quarters. The position peaked at $23K in Q1 2017. 20 funds tracked by Wall St. Rank hold ONCS as of Q3 2017.

  • Acrospire Investment Management reported no remaining OncoSec Medical Incorporated position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 13 OncoSec Medical Incorporated shares in Q3 2017, an estimated $3K.
  • Acrospire Investment Management first reported a position in OncoSec Medical Incorporated in Q2 2016 and held it in 4 quarters.
  • Acrospire Investment Management's OncoSec Medical Incorporated position peaked at $23K in Q1 2017.
  • 20 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.